AC-99-ZN13_10uM Gene Set
| Dataset |
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
|
| Category |
transcriptomics
|
| Type |
drug perturbation |
| Description |
Dose=10uM, Ethoxzolamide, CA2 inhibitor;CA4 inhibitor;CA1 inhibitor;CA7 inhibitor targeting CA1, CA3, CA4, CA5A, CA7, CA8, CA11, CA5B, CA10 (Novartis, 3295)
|
| External Link |
https://pubchem.ncbi.nlm.nih.gov/compound/3295
|
| Similar Terms |
|
| Downloads & Tools |
|
Genes
11 genes differentially expressed following the AC-99-ZN13_10uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
increased expression
| Symbol |
Name |
Standardized Value |
|
FTL
|
ferritin, light polypeptide
|
1.23821
|
|
TRIM16
|
tripartite motif containing 16
|
0.840515
|
|
RPL34
|
ribosomal protein L34
|
0.692149
|
|
TIMM8B
|
translocase of inner mitochondrial membrane 8 homolog B (yeast)
|
0.546468
|
|
TXNRD1
|
thioredoxin reductase 1
|
0.545304
|
|
FTH1
|
ferritin, heavy polypeptide 1
|
0.4231
|
|
PRDX1
|
peroxiredoxin 1
|
0.385603
|
|
BEST1
|
bestrophin 1
|
0.277123
|
|
CSNK2B
|
casein kinase 2, beta polypeptide
|
0.220266
|
decreased expression
| Symbol |
Name |
Standardized Value |
|
NABP1
|
nucleic acid binding protein 1
|
-0.320764
|
|
RRAD
|
Ras-related associated with diabetes
|
-0.210737
|